Cargando…

Contribution of pelvic and para-aortic lymphadenectomy with sentinel node biopsy in patients with IB2–IIB cervical cancer

OBJECTIVE: Detection of lymph node involvement in women with IB2–IIB cervical cancer could have a positive effect on survival. We set out to evaluate the incidence of pelvic and/or para-aortic lymph node involvement using the sentinel node (SN) biopsy and its impact on survival. METHODS: From 2002 t...

Descripción completa

Detalles Bibliográficos
Autores principales: Chéreau, E, Feron, J-G, Ballester, M, Coutant, C, Bezu, C, Rouzier, R, Touboul, E, Daraï, E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3251874/
https://www.ncbi.nlm.nih.gov/pubmed/22146520
http://dx.doi.org/10.1038/bjc.2011.541
_version_ 1782220574502682624
author Chéreau, E
Feron, J-G
Ballester, M
Coutant, C
Bezu, C
Rouzier, R
Touboul, E
Daraï, E
author_facet Chéreau, E
Feron, J-G
Ballester, M
Coutant, C
Bezu, C
Rouzier, R
Touboul, E
Daraï, E
author_sort Chéreau, E
collection PubMed
description OBJECTIVE: Detection of lymph node involvement in women with IB2–IIB cervical cancer could have a positive effect on survival. We set out to evaluate the incidence of pelvic and/or para-aortic lymph node involvement using the sentinel node (SN) biopsy and its impact on survival. METHODS: From 2002 to 2010, 66 women with IB2–IIB cervical cancer underwent a pelvic and paraaortic lymphadenectomy with SN biopsy. Survival between groups according to lymph node status was evaluated. RESULTS: Mean tumour size was 43.5 mm. At least one SN was detected in 69% of the 45 SN procedures performed. Sixteen of these patients had metastatic SN and the false negative rate was 20%. Metastatic pelvic SNs or non-SNs were detected in 33 patients (50%), including pelvic-positive nodes in 26 (40%), pelvic- and paraaortic-positive lymph nodes in seven (11%), and paraaortic skip metastases in two (6%). Positive paraaortic node was the sole determinant for disease-free survival (DFS) and overall survival (OS; P<0.001). Differences in DFS and OS between groups according to the nodal status were observed (P<0.001). CONCLUSION: SN procedure gave a higher rate of metastasis detection. Further studies are required to evaluate whether pre-therapeutic node staging, including paraaortic and pelvic lymphanedectomy, should be performed.
format Online
Article
Text
id pubmed-3251874
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-32518742013-01-03 Contribution of pelvic and para-aortic lymphadenectomy with sentinel node biopsy in patients with IB2–IIB cervical cancer Chéreau, E Feron, J-G Ballester, M Coutant, C Bezu, C Rouzier, R Touboul, E Daraï, E Br J Cancer Clinical Study OBJECTIVE: Detection of lymph node involvement in women with IB2–IIB cervical cancer could have a positive effect on survival. We set out to evaluate the incidence of pelvic and/or para-aortic lymph node involvement using the sentinel node (SN) biopsy and its impact on survival. METHODS: From 2002 to 2010, 66 women with IB2–IIB cervical cancer underwent a pelvic and paraaortic lymphadenectomy with SN biopsy. Survival between groups according to lymph node status was evaluated. RESULTS: Mean tumour size was 43.5 mm. At least one SN was detected in 69% of the 45 SN procedures performed. Sixteen of these patients had metastatic SN and the false negative rate was 20%. Metastatic pelvic SNs or non-SNs were detected in 33 patients (50%), including pelvic-positive nodes in 26 (40%), pelvic- and paraaortic-positive lymph nodes in seven (11%), and paraaortic skip metastases in two (6%). Positive paraaortic node was the sole determinant for disease-free survival (DFS) and overall survival (OS; P<0.001). Differences in DFS and OS between groups according to the nodal status were observed (P<0.001). CONCLUSION: SN procedure gave a higher rate of metastasis detection. Further studies are required to evaluate whether pre-therapeutic node staging, including paraaortic and pelvic lymphanedectomy, should be performed. Nature Publishing Group 2012-01-03 2011-12-06 /pmc/articles/PMC3251874/ /pubmed/22146520 http://dx.doi.org/10.1038/bjc.2011.541 Text en Copyright © 2012 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Clinical Study
Chéreau, E
Feron, J-G
Ballester, M
Coutant, C
Bezu, C
Rouzier, R
Touboul, E
Daraï, E
Contribution of pelvic and para-aortic lymphadenectomy with sentinel node biopsy in patients with IB2–IIB cervical cancer
title Contribution of pelvic and para-aortic lymphadenectomy with sentinel node biopsy in patients with IB2–IIB cervical cancer
title_full Contribution of pelvic and para-aortic lymphadenectomy with sentinel node biopsy in patients with IB2–IIB cervical cancer
title_fullStr Contribution of pelvic and para-aortic lymphadenectomy with sentinel node biopsy in patients with IB2–IIB cervical cancer
title_full_unstemmed Contribution of pelvic and para-aortic lymphadenectomy with sentinel node biopsy in patients with IB2–IIB cervical cancer
title_short Contribution of pelvic and para-aortic lymphadenectomy with sentinel node biopsy in patients with IB2–IIB cervical cancer
title_sort contribution of pelvic and para-aortic lymphadenectomy with sentinel node biopsy in patients with ib2–iib cervical cancer
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3251874/
https://www.ncbi.nlm.nih.gov/pubmed/22146520
http://dx.doi.org/10.1038/bjc.2011.541
work_keys_str_mv AT chereaue contributionofpelvicandparaaorticlymphadenectomywithsentinelnodebiopsyinpatientswithib2iibcervicalcancer
AT feronjg contributionofpelvicandparaaorticlymphadenectomywithsentinelnodebiopsyinpatientswithib2iibcervicalcancer
AT ballesterm contributionofpelvicandparaaorticlymphadenectomywithsentinelnodebiopsyinpatientswithib2iibcervicalcancer
AT coutantc contributionofpelvicandparaaorticlymphadenectomywithsentinelnodebiopsyinpatientswithib2iibcervicalcancer
AT bezuc contributionofpelvicandparaaorticlymphadenectomywithsentinelnodebiopsyinpatientswithib2iibcervicalcancer
AT rouzierr contributionofpelvicandparaaorticlymphadenectomywithsentinelnodebiopsyinpatientswithib2iibcervicalcancer
AT touboule contributionofpelvicandparaaorticlymphadenectomywithsentinelnodebiopsyinpatientswithib2iibcervicalcancer
AT daraie contributionofpelvicandparaaorticlymphadenectomywithsentinelnodebiopsyinpatientswithib2iibcervicalcancer